Post Job

Trinity Biotech CEO and Executives

Executive Summary. Based on our data team's research, Ronan O Caoimh is the Trinity Biotech's CEO. Trinity Biotech has 568 employees, of which 20 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Trinity Biotech executive team is 0% female and 100% male.
  • 55% of the management team is White.
  • 6% of Trinity Biotech management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work At Trinity Biotech?
Share Your Experience

Rate Trinity Biotech's leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Ronan O Caoimh

CEO

Ronan O'Caoimh is a Co-Owner at Jrj Investments, Inc.. He has worked as Finance Director at Noctech Limited, Chairman/CEO/Co-Founder at Trinity Biotech, and CFO/Co-Founder at Trinity Biotech. Ronan works or has worked as FELLOW at Chartered Accountants Ireland. He attended University College Dublin.

Denis Burger

Founder

James Walsh Ph.d

Board Member

James Walsh Ph.d's LinkedIn

Professor Jim Walsh,

Jim Walsh has 25 years general management experience in the Healthcare industry with particular experience in Diagnostics. He is an Executive Director of Trinity Biotech Plc, (NASDAQ: TRIB) an Irish Diagnostics company and is Executive Chairman of Biosensia Ltd. an Irish Point of Care Diagnostics Company. Previously Dr. Walsh was Executive Chairman of GenCell Biosystems Ltd, a Genomics platform company, acquired by Becton Dickenson in October 2014. Until 2010 Dr. Walsh was CEO of Stokes Bio Ltd. a company specialising in the area of Molecular Diagnostics, acquired by Life Technologies. Prior to that Dr. Walsh was Non Executive Director and Chairman of the Rem Comm of PuriCore Plc. (LSE : PURI), Dr. Walsh is also an investor in and a Director of a number of early stage Diagnostic companies, including Enzolve Technologies Ltd. (Paediatric testing), Epona Biotech (Animal Haematology), Crescent Diagnostics Ltd., (Bone Health).

Previously Dr. Walsh was Managing Director of Cambridge Diagnostics Ltd. a wholly owned subsidiary of Alere. Before joining CDL he worked with Fleming GmbH as R&D Manager.

Born in Ireland in 1958, Dr Walsh is a graduate of the National University of Ireland and holds a Doctorate in Inorganic Chemistry and Post Doctorate qualifications in Immunochemistry. Dr. Walsh also holds the position of Professor and Bio-Innovator in Residence at Dublin City University, Ireland

John Gillard

Board Member

Aris Kekedjian

Board Member

Michael Sung Soo Kim

Board Member

Sun-Q Jeon

Board Member

Kevin Tansley

Board Member

Jim Noffsinger

VP R&D

Lakshmanan Suresh

Chief Scientific Officer

Lakshmanan Suresh's LinkedIn

Lakshmanan Suresh is a Clinical Professor at University at Buffalo, Chief Scientific Officer at Trinity Biotech, and Chief Medical Officer at KSL Biomedical and is based in Buffalo, New York. He has worked as Charing Cross Hospitals at London, UK; CSO at Immco Diagnostics; and Clinical Associate Professor at University at Buffalo. Lakshmanan studied at Madras Dental Group between 1989 and 1994 and University at Buffalo between 2001 and 2006.

Do you work at Trinity Biotech?

Does leadership effectively guide Trinity Biotech toward its goals?

Trinity Biotech Jobs

Trinity Biotech Founders

Name & TitleBio
Ronan O Caoimh

CEO

Ronan O'Caoimh is a Co-Owner at Jrj Investments, Inc.. He has worked as Finance Director at Noctech Limited, Chairman/CEO/Co-Founder at Trinity Biotech, and CFO/Co-Founder at Trinity Biotech. Ronan works or has worked as FELLOW at Chartered Accountants Ireland. He attended University College Dublin.

Denis Burger

Founder

Trinity Biotech Board Members

Name & TitleBio
Ronan O Caoimh

CEO

Ronan O'Caoimh is a Co-Owner at Jrj Investments, Inc.. He has worked as Finance Director at Noctech Limited, Chairman/CEO/Co-Founder at Trinity Biotech, and CFO/Co-Founder at Trinity Biotech. Ronan works or has worked as FELLOW at Chartered Accountants Ireland. He attended University College Dublin.

Denis Burger

Founder

James Walsh Ph.d

Board Member

James Walsh Ph.d's LinkedIn

Professor Jim Walsh,

Jim Walsh has 25 years general management experience in the Healthcare industry with particular experience in Diagnostics. He is an Executive Director of Trinity Biotech Plc, (NASDAQ: TRIB) an Irish Diagnostics company and is Executive Chairman of Biosensia Ltd. an Irish Point of Care Diagnostics Company. Previously Dr. Walsh was Executive Chairman of GenCell Biosystems Ltd, a Genomics platform company, acquired by Becton Dickenson in October 2014. Until 2010 Dr. Walsh was CEO of Stokes Bio Ltd. a company specialising in the area of Molecular Diagnostics, acquired by Life Technologies. Prior to that Dr. Walsh was Non Executive Director and Chairman of the Rem Comm of PuriCore Plc. (LSE : PURI), Dr. Walsh is also an investor in and a Director of a number of early stage Diagnostic companies, including Enzolve Technologies Ltd. (Paediatric testing), Epona Biotech (Animal Haematology), Crescent Diagnostics Ltd., (Bone Health).

Previously Dr. Walsh was Managing Director of Cambridge Diagnostics Ltd. a wholly owned subsidiary of Alere. Before joining CDL he worked with Fleming GmbH as R&D Manager.

Born in Ireland in 1958, Dr Walsh is a graduate of the National University of Ireland and holds a Doctorate in Inorganic Chemistry and Post Doctorate qualifications in Immunochemistry. Dr. Walsh also holds the position of Professor and Bio-Innovator in Residence at Dublin City University, Ireland

John Gillard

Board Member

Aris Kekedjian

Board Member

Michael Sung Soo Kim

Board Member

Sun-Q Jeon

Board Member

Kevin Tansley

Board Member

Seon-Kyu Jeon

Chairman

Clint Severson

Board Member

Trinity Biotech Leadership Demographics

Trinity Biotech Gender Distribution in Management Team

  • The Trinity Biotech executive team is 0% female and 100% male.
  • Trinity Biotech is 42% female and 58% male company-wide.
Male
Male
100%
Company-wide: 58%
Female
Female
0%
Company-wide: 42%

Trinity Biotech Executives by Race

Management Team:
  • The most common ethnicity among Trinity Biotech executive officers is White.
  • 55% of the management team is White.
  • 29% of Trinity Biotech's management is Asian.
  • 9% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 66% of employees are White.
  • 13% of employees are Hispanic or Latino.
  • 10% of employees are Black or African American.
  • Management Team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Trinity Biotech Jobs Nearby

Trinity Biotech Executives FAQs

Zippia gives an in-depth look into the details of Trinity Biotech, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Trinity Biotech. The employee data is based on information from people who have self-reported their past or current employments at Trinity Biotech. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Trinity Biotech. The data presented on this page does not represent the view of Trinity Biotech and its employees or that of Zippia.

Trinity Biotech may also be known as or be related to Biopool Us, Inc, TRINITY BIOTECH PLC and Trinity Biotech.